Solasia Pharma K.K. (TYO:4597)
Japan · Delayed Price · Currency is JPY 29.00
+1.00 (3.57%)
Aug 4, 2026, 3:30 PM JST
Solasia Pharma K.K. Cash Flow Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -891 | -876 | -1,961 | -1,135 | -2,492 | -2,442 |
Depreciation & Amortization | 37 | 37 | 195 | 500 | 534 | 495 |
Loss (Gain) From Sale of Assets | - | - | 959 | - | 431 | - |
Loss (Gain) on Equity Investments | 2 | 1 | 4 | 5 | 3 | - |
Other Operating Activities | 25 | 2 | -6 | -36 | -12 | -2 |
Change in Accounts Receivable | -14 | -142 | -164 | 540 | -446 | 51 |
Change in Inventory | -17 | 15 | -5 | -108 | -14 | 4 |
Change in Accounts Payable | -263 | 108 | -92 | -118 | -65 | -626 |
Change in Other Net Operating Assets | - | 8 | 37 | -7 | -13 | 47 |
Operating Cash Flow | -1,121 | -847 | -1,033 | -359 | -2,074 | -2,473 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | - | -1 | - | - | -2 |
Cash Acquisitions | - | - | - | - | -14 | - |
Sale (Purchase) of Intangibles | - | - | - | - | -403 | -161 |
Investment in Securities | -94 | -77 | - | - | - | - |
Other Investing Activities | -3 | -4 | 1 | - | -1 | -1 |
Investing Cash Flow | -97 | -81 | - | - | -418 | -164 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | 500 | - | 500 | - |
Long-Term Debt Repaid | - | - | -500 | - | -500 | -1,000 |
Net Debt Issued (Repaid) | -32 | - | - | - | - | -1,000 |
Issuance of Common Stock | 1,718 | 1,458 | 1,215 | 318 | 2,621 | 1,403 |
Other Financing Activities | -2 | -33 | -35 | -43 | -50 | -42 |
Financing Cash Flow | 1,684 | 1,425 | 1,180 | 275 | 2,571 | 361 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 39 | 5 | 11 | 7 | 10 | 25 |
Miscellaneous Cash Flow Adjustments | - | -2 | -1 | 1 | -1 | 1 |
Net Cash Flow | 505 | 500 | 157 | -76 | 88 | -2,250 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -1,121 | -847 | -1,034 | -359 | -2,074 | -2,475 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -273.42% | -197.44% | -327.21% | -58.18% | -189.93% | -442.75% |
Free Cash Flow Per Share | -4.48 | -3.57 | -5.20 | -2.13 | -13.65 | -19.02 |
Levered Free Cash Flow | -751.75 | -518.63 | -1,252 | 62.13 | -1,949 | -1,667 |
Unlevered Free Cash Flow | -740.5 | -509.88 | -1,249 | 62.13 | -1,937 | -1,653 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 1 | 1 | 1 | - | 1 | 1 |
Cash Income Tax Paid | - | - | 1 | 25 | 28 | 22 |
Change in Working Capital | -294 | -11 | -224 | 307 | -538 | -524 |